We helped a MedTech founder gain long-range runway visibility and plan fundraising ahead of FDA milestones through a 60-month model.
CEO | Pre-Revenue MedTech Startup
(Preparing for FDA submission)
The CEO needed to know whether funding would last through FDA submission and early commercialization. Without a long-range model, hiring decisions were risky, timelines were uncertain, and board members lacked confidence in future capital planning.
No model accounting for R&D, regulatory, clinical, and operating costs
Only short-term cash visibility (6 months)
No sensitivity analysis for delays or overruns
What We Did
Built a comprehensive 60-month financial model
Integrated FDA pathway steps, engineering effort, and hiring plan
Added scenario planning for delays, cost escalations, and alternative pathways
Created a roadmap linking milestones to cash needs and dilution scenarios
Results
Testimonials
We had raised capital to develop our first device but discovered a second opportunity. We didn’t know if we could afford to run both programs in parallel. Faster Cashflow built a 60-month model that clarified our true burn, our funding gap, and the right timing for our next raise. We made a confident decision backed by real financial insight.
COO, Pre-Revenue MedTech Startup